Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palatability of Ritlecitinib Oral Formulations
NCT03916393Phase 1Completed
- Sponsor
- Pfizer
- Start
- Apr 2019
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of ritlecitinib tosilate in alopecia areata (5 arms), sponsored by Pfizer. Primary endpoints: Overall liking of drug formulation, Saltiness of drug formulation and 5 more. Started Apr 2019; status: completed.
02
Drugs
ritlecitinib tosilate
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT03916393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03916393.